Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9
Umashankar K. Ballehaninna, Ronald S. Chamberlain
Tumor Biology (2013) Vol. 34, Iss. 6, pp. 3279-3292
Closed Access | Times Cited: 104

Showing 1-25 of 104 citing articles:

Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
Sónia A. Melo, Linda B. Luecke, Christoph Kahlert, et al.
Nature (2015) Vol. 523, Iss. 7559, pp. 177-182
Open Access | Times Cited: 2532
Protein Glycosylation in Cancer
Sean R. Stowell, Tongzhong Ju, Richard D. Cummings
Annual Review of Pathology Mechanisms of Disease (2015) Vol. 10, Iss. 1, pp. 473-510
Open Access | Times Cited: 748
Nanoplasmonic quantification of tumour-derived extracellular vesicles in plasma microsamples for diagnosis and treatment monitoring
Kai Liang, Fei Liu, Jia Fan, et al.
Nature Biomedical Engineering (2017) Vol. 1, Iss. 4
Open Access | Times Cited: 324
LncRNA co-expression network analysis reveals novel biomarkers for pancreatic cancer
Matteo Giulietti, Alessandra Righetti, Giovanni Principato, et al.
Carcinogenesis (2018) Vol. 39, Iss. 8, pp. 1016-1025
Open Access | Times Cited: 149
Prognostic and predictive markers in pancreatic adenocarcinoma
Nha Le, Malin Sund, Alessio Vinci, et al.
Digestive and Liver Disease (2015) Vol. 48, Iss. 3, pp. 223-230
Open Access | Times Cited: 112
The involvement of exosomes in the diagnosis and treatment of pancreatic cancer
Abakundana Nsenga Ariston Gabriel, Fang Wang, Qinlian Jiao, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 76
Salivary analysis: An emerging paradigm for non‐invasive healthcare diagnosis and monitoring
Caizhi Liao, Xiaofeng Chen, Ying Fu
Deleted Journal (2023) Vol. 1, Iss. 3
Open Access | Times Cited: 32
The bioengineered and multifunctional nanoparticles in pancreatic cancer therapy: Bioresponisive nanostructures, phototherapy and targeted drug delivery
Mohamed J. Saadh, Hala Baher, Yuanji Li, et al.
Environmental Research (2023) Vol. 233, pp. 116490-116490
Closed Access | Times Cited: 32
Prediagnostic Serum Biomarkers as Early Detection Tools for Pancreatic Cancer in a Large Prospective Cohort Study
Brian M. Nolen, Randall E. Brand, Denise Prosser, et al.
PLoS ONE (2014) Vol. 9, Iss. 4, pp. e94928-e94928
Open Access | Times Cited: 89
Serum lactate dehydrogenase predicts prognosis and correlates with systemic inflammatory response in patients with advanced pancreatic cancer after gemcitabine-based chemotherapy
Shu-Lin Yu, Li-Tao Xu, Qi Qi, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 87
Radiolabeled enzyme inhibitors and binding agents targeting PSMA: Effective theranostic tools for imaging and therapy of prostate cancer
M.R.A. Pillai, Raviteja Nanabala, Ajith Joy, et al.
Nuclear Medicine and Biology (2016) Vol. 43, Iss. 11, pp. 692-720
Closed Access | Times Cited: 73
Tumour-associated antigens and their anti-cancer applications
C.-C. Liu, Hui Yang, Ran Zhang, et al.
European Journal of Cancer Care (2016) Vol. 26, Iss. 5, pp. e12446-e12446
Open Access | Times Cited: 63
Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward
Mohammad Aslam Khan, Shafquat Azim, Haseeb Zubair, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 4, pp. 779-779
Open Access | Times Cited: 62
Systematic review on the role of serum tumor markers in the detection of recurrent pancreatic cancer
Lois A. Daamen, Vincent P. Groot, H.D. Heerkens, et al.
HPB (2018) Vol. 20, Iss. 4, pp. 297-304
Open Access | Times Cited: 60
Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients
Wei Li, Tiandong Li, Chenguang Sun, et al.
Molecular Medicine (2022) Vol. 28, Iss. 1
Open Access | Times Cited: 30
Progress on diagnostic and prognostic markers of pancreatic cancer
Yang Hong, Wan Li, Liwen Ren, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 2, pp. 83-99
Open Access | Times Cited: 18
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer
Chae Young Han, Jacob S. Bedia, Wei‐Lei Yang, et al.
British Journal of Cancer (2024) Vol. 130, Iss. 5, pp. 861-868
Open Access | Times Cited: 7
Upregulated exosomic miR-23b-3p plays regulatory roles in the progression of pancreatic cancer
Dayang Chen, Xiongbo Wu, Min Xia, et al.
Oncology Reports (2017) Vol. 38, Iss. 4, pp. 2182-2188
Open Access | Times Cited: 62
MicroRNAs in stool samples as potential screening biomarkers for pancreatic ductal adenocarcinoma cancer.
Jian‐Yu Yang, Yongwei Sun, Dejun Liu, et al.
PubMed (2014) Vol. 4, Iss. 6, pp. 663-73
Closed Access | Times Cited: 58
Biomarkers and Targeted Therapy in Pancreatic Cancer
Fataneh Karandish, Sanku Mallik
Biomarkers in Cancer (2016) Vol. 8s1, pp. BIC.S34414-BIC.S34414
Open Access | Times Cited: 57
Proteomics analysis of bodily fluids in pancreatic cancer
Sheng Pan, Teresa A. Brentnall, Ru Chen
PROTEOMICS (2015) Vol. 15, Iss. 15, pp. 2705-2715
Open Access | Times Cited: 55
Exosomes in Pancreatic Cancer: from Early Detection to Treatment
Emily A. Armstrong, Eliza W. Beal, Jeffery Chakedis, et al.
Journal of Gastrointestinal Surgery (2018) Vol. 22, Iss. 4, pp. 737-750
Closed Access | Times Cited: 47
Current State of “Omics” Biomarkers in Pancreatic Cancer
Beste Turanlı, Esra Yıldırım, Gizem Gülfidan, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 2, pp. 127-127
Open Access | Times Cited: 34
Serum biomarker-based early detection of pancreatic ductal adenocarcinomas with ensemble learning
Nuno R. Nené, Alexander Ney, Tatiana Nazarenko, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 14
Combination of tumour markers CEA and CA19-9 improves the prognostic prediction in patients with pancreatic cancer
D. Reitz, Armin Gerger, Julia Seidel, et al.
Journal of Clinical Pathology (2015) Vol. 68, Iss. 6, pp. 427-433
Closed Access | Times Cited: 49
Page 1 - Next Page

Scroll to top